EIR Nesher Pharmaceuticals (USA) Aug 2008

Farhana Khan FDA$595.00 - Available Now

FDA investigators audited the Nesher Pharmaceuticals (USA) - Saint Louis, MO, United States facility and issued inspectional observation (via FDA 483) on 28 Aug 2008.

Product details

  • Category:
  • Inspection end: 28 Aug 2008
  • Location: Saint Louis, United States
  • FEI: 1937079
Add To Cart